Prime Therapeutics Pa Form PDF Details

The Prime Therapeutics Prior Authorization (PA) form plays a crucial role in the management and authorization of specialty medications under various health plans, including those offered by Blue Cross and Blue Shield of Florida, Inc. (BCBSF), as part of their extended Responsible Rx pharmacy program. Starting from January 1, 2012, the program, which encompasses Prior Authorization, Responsible Step, and Responsible Quantity Programs, has expanded to ensure the judicious use of medications by requiring prior authorization for a list of specified medications, most notably oral oncology agents. This initiative aims to ensure that the selection of patients for these treatments aligns with the product labeling, clinical guidelines, and evidence from clinical studies. Furthermore, BCBSF has classified these oral oncology medications as specialty pharmacy medications, with CVS Caremark Specialty Pharmacy being the preferred provider, potentially affecting members' out-of-pocket costs for these medications. In addition to oral oncology agents, specific drugs and their generic equivalents under newly added programs such as the Responsible Quantity and Responsible Steps Programs will have set dispensing limits and prerequisite requirements, emphasizing the insurer's commitment to balanced, responsible medication use. The PA form, obtainable on the provider's website, is instrumental in facilitating these processes by allowing healthcare providers to request authorization for medications subject to these guidelines, aiming to streamline patient access to necessary treatments while managing costs and ensuring appropriate use.

QuestionAnswer
Form NamePrime Therapeutics Pa Form
Form Length6 pages
Fillable?No
Fillable fields0
Avg. time to fill out1 min 30 sec
Other namesprime therapeutics forms, prime therapeutics prior authorization, prime therapeutics pa form, prime therapeutics pharmacy prior authorization form

Form Preview Example

Page 1 of 6

Effective January 1, 2012, Blue Cross and Blue Shield of Florida, Inc. (BCBSF) and Health Options, Inc. will expand our Responsible Rx pharmacy program for BlueCare, BlueChoice and BlueOptions. Responsible Rx refers to an umbrella of programs including Prior Authorization, Responsible Step and Responsible Quantity programs. Members with endorsements that support these programs may be affected.

Prior Authorization

Effective January 1, 2012, the medications listed below will require prior authorization for coverage under the member’s pharmacy benefit.

Oral Oncology

Afinitor® (everolimus)

Nexavar® (sorafenib)

Temodar® (emozolomide)

Xeloda® (capecitabine)

Caprelsa® (vandetanib)

Oforta® (fludarabine)

Targretin® (bexarotene)

Zelboraf® (vemurafenib)

Gleevec® (imatinib)

Revlimid® (lenalidomide)

Thalomid (thalidomide)

Zolinza® (vorinostat)

Hexalen® (altretamine)

Sprycel® (dasatinib)

Tretinoin® (oral)

Zytiga® (abiraterone)

Hycamtin® (topotecan)

Sutent® (sunitinib)

Tykerb® (lapatinib)

Sylatron® (peginterferon)

Matulane® (procarbazine)

Tarceva® (erlotinib)

Votrient® (pazopanib)

 

Lysodren® (mitotane)

Tasigna® (nilotinib)

Xalkori® (crizotinib)

 

The intent of the Oral Oncology Agents Prior Authorization (PA) program is to ensure appropriate selection of patients for treatment according to product labeling and/or clinical studies and clinical guidelines. Patients currently prescribed therapy with one of these agents will be able to continue their established therapy. New prescriptions after January 1, 2012 will require review.

Pharmaceutical compendia [National Comprehensive Cancer Network (NCCN) Drugs & Biologics Compendium, American Hospital Formulary Service (AHFS) Drug Information, DrugDex, and Clinical Pharmacology] may be consulted to evaluate for medically accepted off-label use. Prior Authorization requests for oral oncology agents will be reviewed when patient-specific documentation is provided.

BCBSFL will also be classifying these oral oncology medications as specialty pharmacy medications, effective January 1, 2012. BCBSF’s preferred specialty pharmacy provider is CVS Caremark Specialty Pharmacy. CVS Caremark’s toll free number is 1-866-278-5108. Some members may pay a higher out

of pocket cost share when using an out-of-network pharmacy for specialty medications.

New Drugs to Existing Programs

Orencia subcutaneous® (abatacept)

Orencia subcutaneous will be added to our Immunomodulators PA program.

Prior authorization request forms are available on the provider website at www.bcbsfl.com under For Providers, then Pharmacy, and the Prior Authorization Program Information and Authorization forms link.

Page 2 of 6

Responsible Quantity Expansion

This program ensures coverage of certain prescription drugs that reflect dosing guidelines of drug manufacturers and the U.S. Food and Drug Administration (FDA). The table below lists all additional medications and limits added to the Responsible Quantity Program effective January 1, 2012. This only applies to members in plans that are part of the Responsible Quantity Program. You can find a complete list of prescription drugs modified in the program at www.bcbsfl.com; select For Providers, Pharmacy, and then click the Responsible Quantity Program Information link.

Additions to the Responsible Quantity Program Effective 1/1/12

Responsible Quantity Program limits also apply to generic drugs where applicable

Brand/ Generic Name

Antidepressants

Strength

Dispensing Limit

Per Month

(unless noted)

Aplenzin

 

30 tabs

 

 

 

bupropion

75 mg

60 tabs

 

 

 

bupropion

100 mg

120 tabs

 

 

 

bupropion SR

100 mg, 150 mg, 200 mg

60 tabs

 

 

 

bupropion ER

150 mg, 300 mg

30 tabs

 

 

 

Celexa (citalopram)

tablets

30 tabs

 

 

 

Celexa (citalopram)

oral solution

600 mL

 

 

 

fluvoxamine

25 mg, 50 mg

30 caps

 

 

 

fluvoxamine

100 mg

90 caps

 

 

 

Lexapro

tablets

30 tabs

 

 

 

Lexapro

oral solution

600mL

 

 

 

Luvox CR

 

60 caps

 

 

 

Maprotiline

 

90 tabs

 

 

 

mirtazapine

7.5 mg, 15 mg, 30 mg, 45 mg

30 tabs

 

 

 

Oleptro

150 mg

45 tabs

 

 

 

Oleptro

300 mg

30 tabs

 

 

 

Paxil (paroxetine)

10 mg, 20 mg, 40mg

30 tabs

 

 

 

Paxil (paroxetine)

30 mg

60 tabs

 

 

 

Paxil (paroxetine)

oral suspension

900 mL

 

 

 

Paxil CR (paroxetine ER)

12.5 mg

30 tabs

 

 

 

Paxil CR (paroxetine ER)

25 mg, 37.5 mg

60 tabs

 

 

 

Pexeva (paroxetine)

10 mg, 20 mg, 40 mg

30 tabs

 

 

 

Pexeva (paroxetine)

30 mg

60 tabs

 

 

 

Prozac (fluoxetine)

10 mg

30 caps/tabs

 

 

 

Prozac (fluoxetine)

20 mg

120 caps/tabs

 

 

 

Prozac (fluoxetine)

40mg

60 caps

 

 

 

fluoxetine

60 mg

30 tabs

 

 

 

Prozac (fluoxetine)

oral solution

600 mL

 

 

 

Prozac weekly (fluoxetine)

 

4 caps / 28 days

 

 

 

Page 3 of 6

Additions to the Responsible Quantity Program Effective 1/1/12

Responsible Quantity Program limits also apply to generic drugs where applicable

 

 

Dispensing Limit

Brand/ Generic Name

Strength

Per Month

 

 

(unless noted)

Viibryd

10 mg, 20 mg, 40 mg

30 tabs

 

 

 

Zoloft (sertraline)

25 mg, 50 mg

30 tabs

 

 

 

Zoloft (sertraline)

100 mg

60 tabs

 

 

 

Zoloft (sertraline)

oral concentrate

300 mL

 

 

 

Anti-infectives

 

 

Dificid

40 tabs / 180 days

Anti-inflammatory

Orencia subcutaneous

4 syringes / 28 days

Diabetes

Juvisync

100 mg/10 mg, 100 mg/20 mg, 100 mg/40

30 tabs

(sitagliptin/simvastatin)

mg

 

Hematology

Xarelto

Xarelto

10 mg

35 tabs / 90 days

15 mg and 20 mg

30 tabs

 

 

Oral Oncology

Afinitor

Caprelsa

Caprelsa

Gleevec

Gleevec

Nexavar

Revlimid

Revlimid

Sprycel

Sprycel

Sutent

Sutent

Tarceva

Tarceva

Tasigna

Thalomid

Thalomid

Tykerb

Votrient

Xalkori

Zelboraf Zolinza

 

30 tablets

100 mg

60 tabs

300 mg

30 tabs

100 mg

90 tabs

400 mg

60 tabs

 

120 tabs

5 mg, 10 mg

30 caps

15 mg, 25 mg

21 caps/28 days

20 mg

60 tabs

50 mg, 70 mg, 80 mg, 100 mg, 140 mg

30 tabs

12.5 mg

90 caps

25 mg, 50 mg

60 caps

25 mg

60 tabs

100 mg, 150 mg

30 tabs

 

120 caps

50 mg, 100 mg

30 caps

150 mg, 200 mg

60 caps

 

180 tabs

 

120 tabs

 

60 caps

 

240 tabs

 

120 caps

 

 

Page 4 of 6

Additions to the Responsible Quantity Program Effective 1/1/12

Responsible Quantity Program limits also apply to generic drugs where applicable

 

 

Dispensing Limit

Brand/ Generic Name

Strength

Per Month

 

 

(unless noted)

Zytiga

 

120 tabs

 

 

 

Pain

Conzip

Nucynta ER

Suboxone/Subutex

30tabs

60tabs

15 tabs / 90 days

Vaccines

Influenza

1 / 90 days

For members requiring a larger monthly quantity than the coverage maximum, based on medical necessity, you may submit a prior authorization request by filling out the Quantity Limit Prior Authorization form at www.bcbsfl.com; select For Providers and then Pharmacy.

Responsible Steps Expansion

Drugs included in Responsible Steps Program and qualifying prerequisites beginning

1/1/12

 

New Programs

Prerequisite(s)

Hyalgan, Orthovisc, Supartz*

Euflexxa, Synvisc, Synvisc One

 

 

Juvisync

metformin, sulfonylureas, metformin/TZD

 

 

combination, metformin/sulfonylurea

 

 

combination, sulfonylurea/TZD combination

*this program is part of our Medical Step Therapy program and only applies medical claims for members in new HMO products that support medical step therapy

Authorization request forms are available on the provider website at www.bcbsfl.com under For Providers, then Pharmacy, then the Responsible Steps Program Information and Authorization Forms link.

Pharmacy Coverage Exclusions

Effective JANUARY 1, 2012, BCBSF commercial pharmacy plans will no longer cover the brand name drugs listed in the table below. However, BCBSF will cover many of their generic alternatives. This exclusion only applies to members in plans that allow pharmacy coverage exclusions.

Drugs not covered

 

Covered alternatives

 

 

 

Benzoyl Peroxide Wash 7% & Cream 5.5% Kit

 

benzoyl peroxide (Rx only)

 

 

 

Veltin gel, Ziana gel

 

clindamycin phosphate topical gel 1%, tretinoin

 

 

topical gel 0.025%

 

 

 

Page 5 of 6

Responsible Rx Expansion

QUESTIONS AND ANSWERS

Responsible Quantity

QUESTION: Why are there limits on the quantity that I can get on my prescription?

ANSWER: BlueCross and BlueShield of Florida has established quantity limits or coverage maximums for certain medications based on manufacturers and FDA approved dosing guidelines.

QUESTION: Will there be limits on all of my medicines?

ANSWER: Only medications included in the Responsible Quantity Program have quantity limits.

QUESTION: My doctor said I had to have this many pills. What can I do?

ANSWER: Responsible Quantity does not prevent you from receiving the medicine your doctor has prescribed for you. The program places a coverage maximum on select medicines filled in a 30-day period. If your doctor prescribed a greater quantity of the medicine for you, we will cover the Responsible Quantity maximum quantity for your usual copayment or coinsurance, and you may pay for the remainder of the quantity prescribed by your doctor. However, if your doctor determines you must have a greater quantity than the limit, your doctor can request an authorization from BlueCross and BlueShield of Florida to have a greater limit covered for you.

Page 6 of 6

Responsible Steps

QUESTION: I received a letter that said I would no longer have coverage for my medication unless I have tried a generic first. I do not like to use generics because I have read that they are not as effective as brand drugs.

ANSWER:

Generic drugs are FDA-approved and proven to be safe and effective for treating certain conditions. Please check with your doctor if a generic drug is right for you.

QUESTION: I have asked my doctor about generics and he/she put me on the brand drug that you are no longer covering. What can I do?

ANSWER: Check with your doctor if a generic drug is right for you. If not, authorization forms for drugs in our Responsible Steps program are available on our website. Your doctor will fill out the form and fax it in for review. Forms are available at www.bcbsfl.com under providers, then pharmacy, then Responsible Steps Program Information and Authorization Forms.

QUESTION: I have taken the prerequisite meds in the past, but it has been longer than the time period required in the responsible steps program. Can I still qualify for coverage?

ANSWER: In order for your claim for a responsible steps drug to be covered, you will need to have a claim for a prerequisite drug within the last 90 days.

QUESTION: It says that current users will not be affected by this step. Does this mean that no matter what, I can still get my prescription filled?

ANSWER: No. In order for your claim for your drug to be covered, you will need to have a claim in our system for a prerequisite drug within the last 90 days. In other words, you have to keep refilling your prescription regularly.

How to Edit Prime Therapeutics Pa Form Online for Free

Having the purpose of allowing it to be as effortless to work with as it can be, we built this PDF editor. The entire process of filling up the prime therapeutics prior authorization forms is going to be straightforward when you follow the next actions.

Step 1: Choose the orange button "Get Form Here" on the website page.

Step 2: The file editing page is currently available. You can add text or change current content.

The next parts will make up the PDF template that you'll be filling out:

completing prime therapeutics prior authorization form fax number stage 1

Include the expected details in the This program ensures coverage of, Additions to the Responsible, Responsible Quantity Program, Brand Generic Name, Strength, Dispensing Limit Per Month unless, Antidepressants Aplenzin, bupropion, bupropion, bupropion SR, bupropion ER, Celexa citalopram, Celexa citalopram, fluvoxamine, and fluvoxamine area.

prime therapeutics prior authorization form fax number This program ensures coverage of, Additions to the Responsible, Responsible Quantity Program, Brand Generic Name, Strength, Dispensing Limit Per Month unless, Antidepressants Aplenzin, bupropion, bupropion, bupropion SR, bupropion ER, Celexa citalopram, Celexa citalopram, fluvoxamine, and fluvoxamine blanks to fill

Point out the most crucial information on the For members requiring a larger, Responsible Steps Expansion, Drugs included in Responsible, New Programs Hyalgan Orthovisc, Juvisync, metformin sulfonylureas, this program is part of our, and Authorization request forms are segment.

prime therapeutics prior authorization form fax number For members requiring a larger, Responsible Steps Expansion, Drugs included in Responsible, New Programs Hyalgan Orthovisc, Juvisync, metformin sulfonylureas, this program is part of our, and Authorization request forms are fields to fill out

Please include the rights and responsibilities of the sides in the ANSWER Check with your doctor if a, QUESTION I have taken the, ANSWER In order for your claim for, QUESTION It says that current, and ANSWER No In order for your claim box.

prime therapeutics prior authorization form fax number ANSWER Check with your doctor if a, QUESTION I have taken the, ANSWER In order for your claim for, QUESTION It says that current, and ANSWER No In order for your claim blanks to fill out

Step 3: Click the Done button to save the document. Now it is obtainable for transfer to your electronic device.

Step 4: To prevent yourself from any kind of risks as time goes on, try to make at least several duplicates of the form.

Watch Prime Therapeutics Pa Form Video Instruction

Please rate Prime Therapeutics Pa Form

1 Votes
If you believe this page is infringing on your copyright, please familiarize yourself with and follow our DMCA notice and takedown process - click here to proceed .